BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Adult Hodgkin lymphoma AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
105 results:

  • 1. [Clinical study of mature B-cell lymphoma in 11 children with chromosome 11 long-arm abnormalities].
    Zhang N; Duan YL; Zhou CJ; Jin L; Yang J; Huang S; Zhang M; Li N
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):924-929. PubMed ID: 38185522
    [No Abstract]    [Full Text] [Related]  

  • 2. hodgkin lymphoma: A disease shaped by the tumor micro- and macroenvironment.
    Masel R; Roche ME; Martinez-Outschoorn U
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101514. PubMed ID: 38092473
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. BET inhibitors induce NF-κB and E2F downregulation in hodgkin and Reed-Sternberg cells.
    Fernández S; Díaz E; Rita CG; Estévez M; Montalbán C; García JF
    Exp Cell Res; 2023 Sep; 430(2):113718. PubMed ID: 37468057
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. myc rearrangement and concurrent high protein expression of C-myc/Bcl2 carry an adverse prognosis in diffuse large B-cell lymphoma.
    Wang X; He J; He H; Shuai Y; Wang L; Li Y; Huang Y; Yu K; Zhao M; Xie T; Li D
    Ann Diagn Pathol; 2023 Oct; 66():152165. PubMed ID: 37348414
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.
    Salmerón-Villalobos J; Castrejón-de-Anta N; Guerra-García P; Ramis-Zaldivar JE; López-Guerra M; Mato S; Colomer D; Diaz-Crespo F; Menarguez J; Garrido-Pontnou M; Andrés M; García-Fernández E; Llavador M; Frigola G; García N; González-Farré B; Martín-Guerrero I; Garrido-Colino C; Astigarraga I; Fernández A; Verdú-Amorós J; González-Muñíz S; González B; Celis V; Campo E; Balagué O; Salaverria I
    Blood; 2023 Aug; 142(5):434-445. PubMed ID: 37053555
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The evaluation of gene mutation profiles by next-generation sequencing in diffuse large B-cell lymphoma.
    Özçalımlı A; Erdoğdu İH; Turgutkaya A; Yavaşoğlu İ; Döger FK; Bolaman AZ
    Int J Lab Hematol; 2023 Jun; 45(3):310-316. PubMed ID: 36576110
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Richter transformation in Chronic Lymphocytic Leukemia.
    Innocenti I; Benintende G; Tomasso A; Fresa A; Autore F; Larocca LM; Laurenti L
    Hematol Oncol; 2023 Aug; 41(3):293-300. PubMed ID: 36433773
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Two cases of follicular lymphoma with myc gene abnormalities that presented with bone marrow necrosis.
    Miyazawa Y; Takei H; Kobayashi N; Akashi N; Sairenji Y; Sugisaki M; Naito C; Ishikawa T; Shimizu H; Ishizaki T; Yokohama A; Tsukamoto N; Yoshida Y; Matsumura N; Takayama Y; Handa H
    J Clin Exp Hematop; 2022 Dec; 62(4):208-216. PubMed ID: 36261333
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy.
    Diamond JR; Boni V; Lim E; Nowakowski G; Cordoba R; Morillo D; Valencia R; Genvresse I; Merz C; Boix O; Frigault MM; Greer JM; Hamdy AM; Huang X; Izumi R; Wong H; Moreno V
    Clin Cancer Res; 2022 Apr; 28(7):1285-1293. PubMed ID: 35046056
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial.
    Chiappella A; Diop F; Agostinelli C; Novo M; Nassi L; Evangelista A; Ciccone G; Di Rocco A; Martelli M; Melle F; Moia R; Motta G; Righi S; Santambrogio E; Tucci A; Balzarotti M; Ladetto M; Pileri SA; Gaidano G; Vitolo U;
    Br J Haematol; 2022 Mar; 196(5):1184-1193. PubMed ID: 34951009
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses.
    Landsburg DJ; Barta SK; Ramchandren R; Batlevi C; Iyer S; Kelly K; Micallef IN; Smith SM; Stevens DA; Alvarez M; Califano A; Shen Y; Bosker G; Parker J; Soikes R; Martinez E; von Roemeling R; Martell RE; Oki Y
    Br J Haematol; 2021 Oct; 195(2):201-209. PubMed ID: 34341990
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis.
    Ren S; Cai Y; Hu S; Liu J; Zhao Y; Ding M; Chen X; Zhan L; Zhou X; Wang X
    Biochem Pharmacol; 2021 Jun; 188():114576. PubMed ID: 33930347
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Revisiting Richter transformation in the era of novel CLL agents.
    Petrackova A; Turcsanyi P; Papajik T; Kriegova E
    Blood Rev; 2021 Sep; 49():100824. PubMed ID: 33775465
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma.
    Youssef Y; Karkhanis V; Chan WK; Jeney F; Canella A; Zhang X; Sloan S; Prouty A; Helmig-Mason J; Tsyba L; Hanel W; Zheng X; Zhang P; Chung JH; Lucas DM; Kauffman Z; Larkin K; Strohecker AM; Ozer HG; Lapalombella R; Zhou H; Xu-Monette ZY; Young KH; Han R; Nurmemmedov E; Nuovo G; Maddocks K; Byrd JC; Baiocchi RA; Alinari L
    Haematologica; 2021 Nov; 106(11):2927-2939. PubMed ID: 33054136
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Burkitt lymphoma - Subtypes, Pathogenesis, and treatment Strategies.
    Noy A
    Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S37-S38. PubMed ID: 32862862
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High-grade B-cell lymphoma with myc and BCL6 rearrangements presenting as a cervical mass.
    Costa PA; Needelman BS; Tjendra Y; Hoffman JE
    BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843454
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization.
    Kang KW; Lee SJ; Kim JH; Lee BH; Kim SJ; Park Y; Kim BS
    BMC Cancer; 2020 Jul; 20(1):619. PubMed ID: 32615949
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Non-diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases.
    Maeshima AM; Taniguchi H; Ida H; Hosoba R; Fujino T; Saito Y; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
    Hum Pathol; 2020 Aug; 102():33-43. PubMed ID: 32540222
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impact of myc in HIV-associated non-hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial).
    Ramos JC; Sparano JA; Chadburn A; Reid EG; Ambinder RF; Siegel ER; Moore PC; Rubinstein PG; Durand CM; Cesarman E; Aboulafia D; Baiocchi R; Ratner L; Kaplan L; Capoferri AA; Lee JY; Mitsuyasu R; Noy A
    Blood; 2020 Sep; 136(11):1284-1297. PubMed ID: 32430507
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CD56-positive diffuse large B-cell lymphoma/leukemia with
    Liu Y; Shen J; Awal Issah M; Liu T; Zhou H; Fu H
    J Int Med Res; 2020 May; 48(5):300060520918087. PubMed ID: 32363958
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.